Related Experiment Videos
The p53/IGF-1 receptor axis in the regulation of programmed cell death
M Neuberg1, L Buckbinder, B Seizinger
1Department of Molecular Genetics, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ, USA.
Abstract:
The loss or functional inactivation of tumor suppressor genes appears to be one of the most fundamental genetic mechanisms of tumorigenesis, and rational insights into the signaling pathways of tumor suppressor genes have emerged as a successful strategy of identifying novel drug discovery targets downstream of the tumor suppressor protein itself. Elucidation of novel pathways downstream of p53 have established a link between this important tumor suppressor gene and the insulin-like growth factor-1 receptor (IGF-1r), either via direct regulation of IGF-1 receptor levels, or modulation of IGFs via transactivation of the insulin-like growth factor-binding protein 3 (IGF-BP3) gene. Binding of IGF-BP3 to IGFs inhibits both their mitogenic and cell survival functions, highlighting a novel pathway whereby p53 may regulate apoptosis in tumor cells.
Insights
Tumor suppressor gene inactivation drives cancer. The p53 gene links to the insulin-like growth factor-1 receptor (IGF-1r) pathway, potentially regulating apoptosis in tumor cells via IGF-BP3.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Tumor suppressor gene inactivation is a key mechanism in tumorigenesis.
- Understanding tumor suppressor signaling pathways aids drug discovery.
- The p53 tumor suppressor gene plays a critical role in cancer development.
Purpose of the Study:
- To elucidate novel signaling pathways downstream of the p53 tumor suppressor gene.
- To establish a link between p53 and the insulin-like growth factor-1 receptor (IGF-1r) pathway.
- To identify potential therapeutic targets for cancer treatment.
Main Methods:
- Investigated the molecular mechanisms linking p53 to IGF-1r signaling.
- Analyzed the regulation of IGF-1r levels by p53.
- Studied the transactivation of insulin-like growth factor-binding protein 3 (IGF-BP3) by p53.
- Assessed the role of IGF-BP3 in modulating IGF functions.
Main Results:
- A novel pathway linking p53 to IGF-1r signaling was identified.
- p53 was found to directly regulate IGF-1r levels or modulate IGFs via IGF-BP3 transactivation.
- IGF-BP3 binding to IGFs inhibits their mitogenic and cell survival functions.
- This pathway provides a mechanism for p53 to regulate apoptosis in tumor cells.
Conclusions:
- The p53 gene is linked to the IGF-1r pathway, offering new insights into tumor suppression.
- Targeting the p53-IGF-1r-IGF-BP3 axis may represent a novel therapeutic strategy for cancer.
- Further research into this pathway could lead to the development of innovative anti-cancer drugs.